Clinical Trial Update: Using KomPas+ in the Treatment of Patients With Intermittent Claudication [NA]

View source ↗

Summary

A clinical trial evaluating KomPas+ for intermittent claudication associated with peripheral arterial disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intermittent Claudication
• Peripheral Arterial Disease

Drugs mentioned

• KomPas+

Snippet

Sponsor: Radboud University Medical Center | Conditions: Intermittent Claudication, Peripheral Arterial Disease | NA | Status: COMPLETED